Fate Therapeutics
(FATE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,020 | 61,333 | 82,093 | 55,275 | 64,741 |
| Marketable Securities | 366,878 | 374,894 | 423,043 | 513,575 | 509,031 |
| Receivables | 13,500 | 38,480 | 10,223 | 13,126 | 13,850 |
| TOTAL | $437,888 | $502,074 | $535,329 | $599,157 | $599,075 |
| Non-Current Assets | |||||
| PPE Net | 108,594 | 110,020 | 109,118 | 103,116 | 97,857 |
| Investments And Advances | 3,912 | 4,942 | 13,939 | 11,925 | 67,942 |
| Other Non-Current Assets | 79,942 | 88,525 | 90,963 | 92,861 | 93,512 |
| TOTAL | $192,448 | $203,487 | $214,020 | $207,902 | $259,311 |
| Total Assets | $630,336 | $705,561 | $749,349 | $807,059 | $858,386 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,855 | 8,265 | 9,593 | 8,420 | 11,444 |
| Accrued Expenses | 31,513 | 53,932 | 50,149 | 40,524 | 35,110 |
| Other current liabilities | N/A | 4,000 | 3,200 | 3,200 | 3,200 |
| TOTAL | $48,651 | $114,051 | $103,938 | $91,518 | $77,911 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,738 | 42,226 | 35,241 | 33,657 | 22,575 |
| Other Non-Current Liabilities | 104,213 | 107,571 | 115,001 | 117,315 | 124,548 |
| TOTAL | $104,213 | $107,571 | $127,408 | $135,058 | $147,082 |
| Total Liabilities | $152,864 | $221,622 | $231,346 | $226,576 | $224,993 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,384 | 98,162 | 97,170 | 97,000 | 96,629 |
| Common Shares | 98 | 97 | 97 | 97 | 97 |
| Retained earnings | -1,069,685 | -1,050,804 | -994,441 | -910,878 | -834,773 |
| Other shareholders' equity | -643 | -1,851 | -3,250 | -3,378 | -2,847 |
| TOTAL | $477,472 | $483,939 | $518,003 | $580,483 | $633,393 |
| Total Liabilities And Equity | $630,336 | $705,561 | $749,349 | $807,059 | $858,386 |